Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02269345 · ClinicalTrials.gov registry record · NA
Auricular Acupuncture in Ureteral Stent Pain
A NA study, sponsored by Mike O'Callaghan Military Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT02269345 is a NA study that was terminated before completion, run by Mike O'Callaghan Military Hospital. The registered enrollment target is 34 participants.
The verdict
NCT02269345, a NA study, was terminated before completion, sponsored by Mike O'Callaghan Military Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The investigators propose to complete a randomized controlled trial to compare battlefield auricular acupuncture at five points in right ear and five points in left ear (cingulate gyrus, thalamus, omega 2, point zero, and shen men) plus standard of care, versus standard of care alone, for symptomatic treatment of stent pain in postoperative ureteral stent patients. Male and female DoD beneficiaries ages 18 years or older, who are scheduled for elective urologic surgery that would be expected to have the routine placement of a ureteral stent (ureteroscopy, ureteroscopy with biopsy, ureteroscopy with laser treatment of a stone, ESWL of stone greater than 10mm) will be recruited. Subjects will be followed up at 24 hours post surgery, 48 hours, 1 week, 1 month, and 1 month post surgery. The investigators will ask subjects to rate their pain level on a 0-10 analogue scale, the investigators will assess via the Ureteric Stent Symptoms Questionnaire (USSQ) subjects' urinary urgency, urinary frequency, and quality of life. The investigators will ask subjects how many pills they have taken for their pain including the quantity and dose to assess a reduction in pain medication use.
Interventions
- OTHER Standard Treatment
- OTHER Battlefield Acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2015-02 |
| Est. Completion | 2020-05-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02269345
The ClinicalTrials.gov registry entry for NCT02269345 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mike O'Callaghan Military Hospital, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Treatment is the first listed.
NCT02269345 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02269345 about?
NCT02269345 is a clinical study titled "Auricular Acupuncture in Ureteral Stent Pain". The investigators propose to complete a randomized controlled trial to compare battlefield auricular acupuncture at five points in right ear and five points in left ear (cingulate gyrus, thalamus, omega 2, point zero, and shen men) plus standard of care, versus standard of care alone, for symptomati...
What is the current status of trial NCT02269345?
This trial is currently terminated. It is a NA study. The enrollment target is 34 participants. The study started on 2015-02. Estimated completion is 2020-05-12.
What interventions are being tested in trial NCT02269345?
The interventions under investigation include: Standard Treatment (OTHER), Battlefield Acupuncture (OTHER).
Who is sponsoring clinical trial NCT02269345?
This trial is sponsored by Mike O'Callaghan Military Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.